EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 183 filers reported holding EAGLE PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 1.51 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,871,484 | +319.1% | 65,967 | +331.8% | 0.00% | +300.0% |
| Q4 2022 | $446,517 | -54.4% | 15,276 | -34.9% | 0.00% | -75.0% |
| Q1 2021 | $979,000 | -66.4% | 23,449 | -54.5% | 0.00% | -82.6% |
| Q3 2019 | $2,918,000 | +47.4% | 51,590 | +45.1% | 0.02% | +43.8% |
| Q2 2019 | $1,979,000 | -61.0% | 35,550 | -64.6% | 0.02% | -33.3% |
| Q1 2019 | $5,068,000 | +12.9% | 100,376 | -9.9% | 0.02% | -47.8% |
| Q4 2018 | $4,490,000 | +1878.0% | 111,464 | +2492.2% | 0.05% | +411.1% |
| Q1 2018 | $227,000 | -94.1% | 4,300 | -90.9% | 0.01% | -82.0% |
| Q2 2015 | $3,842,000 | – | 47,509 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Park West Asset Management LLC | 1,120,235 | $53,749,000 | 2.66% |
| TANG CAPITAL MANAGEMENT LLC | 255,616 | $12,264,000 | 1.19% |
| Smith, Graham & Co., Investment Advisors, LP | 158,671 | $7,613,000 | 0.92% |
| ARMISTICE CAPITAL, LLC | 282,000 | $13,530,000 | 0.59% |
| Capital Impact Advisors, LLC | 35,815 | $1,718,000 | 0.57% |
| Matarin Capital Management, LLC | 58,977 | $2,830,000 | 0.56% |
| GLOBEFLEX CAPITAL L P | 31,702 | $1,521,000 | 0.39% |
| CHARTWELL INVESTMENT PARTNERS, LLC | 200,246 | $9,608,000 | 0.37% |
| Stanley-Laman Group, Ltd. | 24,000 | $1,152,000 | 0.28% |
| VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. | 264 | $13,000 | 0.20% |